BNP PARIBAS FINANCIAL MARKETS - AXOVANT GENE THERAPIES LTD ownership

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$5,000
+66.7%
10.0%0.00%
Q2 2020$3,000
-88.9%
1
-90.9%
0.00%
Q1 2020$27,000
-51.8%
110.0%0.00%
Q4 2019$56,000
-88.7%
11
-85.7%
0.00%
Q3 2019$497,000
+3.5%
770.0%0.00%
Q2 2019$480,000770.00%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2020.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders